theophylline has been researched along with Hyperlipidemias in 26 studies
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The investigation was aimed at evaluating the feasibility of an animal model of hyperlipidemia for pharmacokinetic studies of theophylline in humans suffering from lipid metabolism disturbances." | 2.68 | [Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans]. ( Górnik, W, 1996) |
| "Utilizing a hyperlipidemia Sprague-Dawley model and UPLC-MS/MS metabolomics, we examined how the effect of Liupao and green tea extracts on hyperlipidemia and antoxidant enzyme levels and compared their constituents." | 1.72 | Antihyperlipidemic effect and increased antioxidant enzyme levels of aqueous extracts from Liupao tea and green tea in vivo. ( Chen, H; Huang, L; Huang, S; Teng, J; Wei, B; Wu, Z; Xia, N, 2022) |
| "Hyperlipidemia is a risk factor for the development of cognitive dysfunction and atherosclerosis." | 1.46 | Guarana (Paullinia cupana) ameliorates memory impairment and modulates acetylcholinesterase activity in Poloxamer-407-induced hyperlipidemia in rat brain. ( Abdalla, FH; Adefegha, SA; Braun, JBS; Castilhos, LG; da Silva, CB; de Oliveira, JS; Guedes Manzoni, A; Leal, DBR; Lopes, STA; Rubin, MA; Ruchel, JB; Signor, C; Trelles, K, 2017) |
| " Marked decrease in area under the concentration-time curve (AUC), diminished volume of distribution, increased total body clearance, and shortened elimination half-life were observed." | 1.29 | Comparative pharmacokinetics of theophylline in rabbits and in humans with hyperlipidemia. ( Droździk, M; Gawrońska-Szklarz, B; Górnik, W; Pawlik, A; Wójcicki, J, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (76.92) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S | 1 |
| Chen, H | 1 |
| Teng, J | 1 |
| Wu, Z | 1 |
| Huang, L | 1 |
| Wei, B | 1 |
| Xia, N | 1 |
| Ruchel, JB | 2 |
| Bernardes, VM | 1 |
| Braun, JBS | 2 |
| Manzoni, AG | 1 |
| Passos, DF | 1 |
| Castilhos, LG | 2 |
| Abdalla, FH | 2 |
| de Oliveira, JS | 2 |
| de Andrade, CM | 1 |
| Casali, EA | 1 |
| da Cruz, IBM | 1 |
| Leal, DBR | 2 |
| Adefegha, SA | 1 |
| Guedes Manzoni, A | 1 |
| Trelles, K | 1 |
| Signor, C | 1 |
| Lopes, STA | 1 |
| da Silva, CB | 1 |
| Rubin, MA | 1 |
| WENNERBY, S | 1 |
| Dhorranintra, B | 1 |
| Khunawat, P | 1 |
| Patalung, BN | 1 |
| Prabhan, C | 1 |
| Baumann, J | 1 |
| Martschick, R | 1 |
| Wójcicki, J | 2 |
| Górnik, W | 2 |
| Pawlik, A | 1 |
| Droździk, M | 1 |
| Gawrońska-Szklarz, B | 1 |
| Nakura, H | 1 |
| Tateishi, T | 1 |
| Watanabe, M | 1 |
| Asoh, M | 1 |
| Tanaka, M | 1 |
| Kumai, T | 1 |
| Kobayashi, S | 1 |
| Haacke, H | 4 |
| Parwaresch, MR | 4 |
| Mäder, C | 4 |
| Metz, G | 1 |
| Specker, M | 1 |
| Sterner, W | 1 |
| Heisler, E | 1 |
| Grahwit, G | 1 |
| Rube, O | 1 |
| Walldius, G | 1 |
| Klimm, HD | 1 |
| Lasso, M | 1 |
| García Merlo, S | 1 |
| Alvarez, C | 1 |
| Franzone, JS | 1 |
| Cirillo, R | 1 |
| Reboani, MC | 1 |
| Torrielli, MV | 1 |
| Pernigotti, LM | 1 |
| Samochowiec, L | 1 |
| Bartłomowicz, B | 1 |
| Kadłubowska, D | 1 |
| Marona, H | 1 |
| Jover Sanz, E | 1 |
| Paradinas Jiménez, C | 1 |
| Corporales López, L | 1 |
| Martínez Robles, JV | 1 |
| Möller-Hardenack, B | 1 |
| Ferrer García, JL | 1 |
| Ciammaichella, A | 1 |
| Eaton, RP | 1 |
| Kipnis, DM | 1 |
| Zeller, W | 1 |
| Christ, F | 1 |
| Quinton, A | 1 |
3 trials available for theophylline and Hyperlipidemias
| Article | Year |
|---|---|
Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic A | 1983 |
[Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
Topics: Adult; Aged; Cholesterol; Dietary Fats; Drug Tolerance; Humans; Hyperlipidemias; Middle Aged; Theoph | 1982 |
[Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans].
Topics: Adult; Animals; Area Under Curve; Disease Models, Animal; Female; Humans; Hyperlipidemias; Male; Mid | 1996 |
23 other studies available for theophylline and Hyperlipidemias
| Article | Year |
|---|---|
Antihyperlipidemic effect and increased antioxidant enzyme levels of aqueous extracts from Liupao tea and green tea in vivo.
Topics: Antioxidants; Bile Acids and Salts; Catalase; Cholesterol, LDL; Chromatography, Liquid; Ellagic Acid | 2022 |
Lipotoxicity-associated inflammation is prevented by guarana (
Topics: Adenosine; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Caffeine; Disease Models, Anim | 2021 |
Guarana (Paullinia cupana) ameliorates memory impairment and modulates acetylcholinesterase activity in Poloxamer-407-induced hyperlipidemia in rat brain.
Topics: Acetylcholinesterase; Animals; Blood Glucose; Brain; Caffeine; Cholesterol; Hyperlipidemias; Male; M | 2017 |
[COMPLAMINE TREATMENT OF PATIENTS WITH INCREASED SERUM CHOLESTEROL VALUES].
Topics: Cholesterol; Coronary Disease; Humans; Hypercholesterolemia; Hyperlipidemias; Niacin; Nicotinic Acid | 1964 |
Comparative pharmacokinetics of theophylline in rabbits and in humans with hyperlipidemia.
Topics: Adult; Animals; Dietary Fats; Female; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Phosphodie | 1996 |
Effect of hypoalbuminemia on the disposition of theophylline. Comparative study with Sprague-Dawley rats and a mutant Sprague-Dawley hyperlipidemic strain with hypoalbuminemia.
Topics: Animals; Bronchodilator Agents; Hyperlipidemias; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; S | 1998 |
[Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
Topics: Adult; Aged; Body Weight; Cholesterol; Chylomicrons; Fatty Acids, Nonesterified; Female; Humans; Hyp | 1976 |
[Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
Topics: Adolescent; Adult; Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Li | 1977 |
1-(Theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (ML 1024), a new hypolipemic agent.
Topics: Animals; Blood Pressure; Dogs; Female; Hyperlipidemias; Male; Mice; Pregnancy; Propionates; Rabbits; | 1977 |
[Effect of lipid-lowering treatment with xanthinol-nicotinate on the carbohydrate metabolism in mature-onset diabetics and non-diabetic patients with hyperlipoproteinemias (HLP)].
Topics: Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; The | 1978 |
Fatty acid incorporation into human adipose tissue (FIAT) in hypertriglyceridaemia.
Topics: Adipose Tissue; Adult; Aged; Anesthesia; Biopsy, Needle; Fatty Acids; Female; Glucose; Glucose Toler | 1976 |
[Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
Topics: Female; Humans; Hyperlipidemias; Male; Theophylline; Xanthinol Niacinate | 1976 |
[The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV].
Topics: Humans; Hyperlipidemias; Lipids; Lipoproteins; Theophylline; Xanthinol Niacinate | 1976 |
[Long-term hypolipemic therapy in arteriosclerosis obliterans].
Topics: Aged; Anticholesteremic Agents; Arteriosclerosis Obliterans; Diet Therapy; Dietary Fats; Humans; Hyp | 1976 |
Effect of teomorfolin [N-(7'-theophylline acetyl)morpholine], a new drug, on dislipidaemic conditions induced in the rat.
Topics: Adenosine Diphosphate; Animals; Blood Glucose; Diet, Atherogenic; Epoprostenol; Erythrocyte Deformab | 1988 |
[Hypolipemic and antiatherogenic effects of 2',4' dichlorobenzoate of 7-gamma(beta-hydroxypropyl)-theophylline (HME2)].
Topics: Animals; Arteriosclerosis; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Rabbits; Rats; Rats, | 1988 |
[Therapy of hyperlipemias with lipolytic drugs].
Topics: Adult; Cholesterol; Drug Combinations; Esters; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; | 1974 |
[Therapy of hyperlipemia using xantinol-nicotinate].
Topics: Aged; Amino Alcohols; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hyperlipidemia | 1973 |
[Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
Topics: Adult; Aged; Arteriosclerosis; Drug Combinations; Esters; Female; Humans; Hyperlipidemias; Male; Mid | 1973 |
[On the treatment of hyperlipemia with theophylline nicotinate].
Topics: Aged; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Embolism; Humans; Hyperlipidemi | 1969 |
Effects of high-carbohydrate diets on lipid and carbohydrate metabolism in the rat.
Topics: Animals; Blood Glucose; Blood Protein Electrophoresis; Body Weight; Carbohydrate Metabolism; Cholest | 1969 |
[Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
Topics: Arteriosclerosis; Coronary Disease; Drug Synergism; Heparin; Humans; Hyperlipidemias; Myocardial Inf | 1966 |
[Therapeutic actions of Pyridofylline in dyspnea, hyperlipemia and certain hepatobiliary diseases].
Topics: Adult; Biliary Tract Diseases; Dyspnea; Female; Humans; Hyperlipidemias; Liver Diseases; Male; Pyrid | 1966 |